Lymph node biopsy does not impair survival after therapeutic dissection for palpable melanoma metastases

Annals of Surgical Oncology

Volumn 6, Issue 2, 1999, Pages 139-143

  Kelemen, Pond R ^a   Wanek, Leslie A ^a   Morton, Donald L ^a  

^a JOHN WAYNE CANCER INSTITUTE   (United States)

Author keywords

Dissection; Lymph node; Melanoma; Survival

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; ASPIRATION BIOPSY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; LYMPH NODE BIOPSY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MELANOMA; NECK DISSECTION; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0032912192     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10434-999-0139-8     Document Type: Article

References (19)

1. Ketcham AS, Balch CM. Classification and staging systems. In: Balch CM, Milton GW, eds. Cutaneous melanoma: clinical management and treatment results worldwide. Philadelphia: JB Lippincott, 1985.
2. Morton DL, Wanek L, Nizze JA, Elashoff RM, Wong JH. Improved long term survival after lymphadenectomy of melanoma metastatic to regional nodes. Ann Surg 1991;214:491-501.
3. Warso MA, Das Gupta TK. Melanoma recurrence in a previously dissected lymph node basin. Arch Surg 1994;129:252-5.
4. Karakousis CP, Emerich LJ, Driscoll DL, Rao U. Survival after groin dissection for malignant melanoma. Surgery 1991;109:119-26.
5. Martin H, Romieu C. The diagnostic significance of a "lump in the neck." Postgrad Med 1952;11:491-500.
6. Anbari KK, Schuchter LM, Bucky LP, et al. Melanoma of unknown primary site: presentation, treatment, and prognosis: a single institution study: University of Pennsylvania Pigmented Lesion Study Group. Cancer 1997;79:1816-21.
7. Morton DL. Surgical treatment for malignant melanoma. Clin Oncol 1984;3:517-29.
8. Finck SJ, Giuliano AE, Mann BD, Morton DL. Results of ilioinguinal dissection for stage II melanoma. Ann Surg 1982;196: 180-6.
9. Storm FK, Eilber FR, Morton DL, Clark WH Jr. Malignant melanoma of the head and neck. Head Neck Surg 1978;1:123-8.
10. Wanek LA, Elashoff RM, Goradia TM, Morton DL, Cochran AJ. Application of multistage Markov modeling to malignant melanoma progression. Cancer 1994;73:336-43.
11. Kane M, McClay E, Bellet RE. Frequency of occult residual melanoma after excision of a clinically positive regional lymph node. Ann Surg 1987;205:88-9.
12. Karakousis CP, Rizos S, Driscoll DL. Residual nodal disease after excisional biopsy of a palpable, positive node in melanoma. Am J Surg 1994;168:69-70.
13. Singluff CL Jr, Stidham KR, Ricci WM, Stanley WE, Seigler HF. Surgical management of regional lymph nodes in patients with melanoma: experience with 4682 patients. Ann Surg 1994;2:120-30.
14. Coates AS, Ingvar CI, Petersen-Schaefer K, et al. Elective lymph node dissection in patients with primary melanoma of the trunk and limbs treated at the Sydney Melanoma Unit from 1960 to 1991. J Am Coll Surg 1995;180:402-9.
15. Gadd MA, Coit DG. Recurrence patterns and outcome in 1019 patients undergoing axillary or inguinal lymphadenectomy for melanoma. Arch Surg 1992;127:1412-6.
16. Monsour PD, Sause WT, Avent JM, Noyes RD. Local control following therapeutic nodal dissection for melanoma. J Surg Oncol 1993;54:18-22.
17. Byers RM. The role of modified neck dissection in the treatment of cutaneous melanoma of the head and neck. Arch Surg 1986;121: 1338-41.
18. Bowsher WG, Taylor BA, Hughes LE. Morbidity, mortality, and local recurrence following regional node dissection for melanoma. Br J Surg 1986;73:906-8.
19. Buzaid AC, Tinoco LA, Jendiroba D, et al. Prognostic value of size of lymph node metastases in patients with cutaneous melanoma. J Clin Oncol 1995;13:2361-8.